Description
Advanced PBPK (Physiologically Based Pharmacokinetic) modeling and simulation software specifically designed for pediatric pharmacokinetics. Predicts drug behavior in diverse pediatric populations using sophisticated modeling techniques.
Market positioning
Premium market leader in pediatric pharmacokinetic modeling and simulation software
Target audience
Pharmaceutical companies, clinical researchers, regulatory agencies, and healthcare professionals working with pediatric drug development and dosing optimization
Use cases
Pediatric drug development, dosing optimization, regulatory submissions, clinical trial design, and safety assessment for pediatric populations
Company information
Company size
Large Enterprise (1000+ employees)
Revenue
$300M+ annually
Scale
Global
Number of users
500-1000 active users globally
Features
Pricing
Rating
No Trustpilot link available
Pros and cons
Based on: (AI summary)
Pros
- Advanced PBPK modeling technology
- Specialized pediatric focus
- Regulatory acceptance and adoption
- Comprehensive population modeling
- Strong scientific foundation
Cons
- Likely high cost for smaller organizations
- Complex software requiring specialized training
- May be overkill for basic dosing needs
- Requires significant computational resources
Feature Comparison
Top features across 5 competitors (most common first)
| Feature | PrecisePK T… | Simcyp Pedi… | Clinical Ph… | Model-Infor… | Physiologic… |
|---|---|---|---|---|---|
| immunosuppressives | |||||
| biologics | |||||
| Acute Kidney Injury (AKI) prediction tool | |||||
| Bayesian-guided precision dosing | |||||
| Model-Informed Precision Dosing (MIPD) | |||||
| Multi-language support (English | |||||
| Spanish | |||||
| Chinese | |||||
| Thai | |||||
| Korean) | |||||
| Multiple drug modules | |||||
| Real-time monitoring and analytics | |||||
| SOC2 and ISO/IEC 27001 compliance | |||||
| Vancomycin AUC dosing calculator | |||||
| Advanced PBPK modeling and simulation | |||||
| Pediatric population modeling | |||||
| Diverse population analysis | |||||
| Drug behavior prediction | |||||
| Advanced simulation capabilities | |||||
| Regulatory-ready modeling |